IBD
Myths and Misconceptions in the Management of Elderly Patients With Inflammatory Bowel Disease
Abstract: For decades, antimicrobial therapy for Helicobacter pylori infection has been given empirically, and the results of therapy (success or failure) have either not been confirmed […]
Abstract: For decades, antimicrobial therapy for Helicobacter pylori infection has been given empirically, and the results of therapy (success or failure) have either not been confirmed […]
Abstract: Cholangiocarcinoma (CCA) is a neoplasm of the biliary tract that has become increasingly prevalent throughout the world. Common risk factors for developing CCA include cirrhosis, […]
Abstract: Iron overload disorders are conditions that can lead to increased body iron stores and end-organ damage in affected organs. Increased iron deposition most commonly occurs […]
A Review of Selected Presentations From ACG 2022 October 21-26, 2022 • Charlotte, North Carolina Duration of Response to Ozanimod After Treatment Withdrawal: Results From the […]
A Review of Selected Presentations From DDW 2022 • May 21-24, 2022 • San Diego, California Recapture of Response With Ozanimod in Patients With Moderately […]
Rapidity of Ozanimod-Induced Symptomatic Response and Remission in Patients With Moderately to Severely Active Ulcerative Colitis: Results From the Induction Period of True North Ozanimod is […]
Abstract: Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease worldwide. It represents a spectrum of disease from simple hepatic steatosis to steatohepatitis […]
Abstract: Consultation for liver disease during pregnancy is challenging for both the hepatologist and gynecologist, as normal physiologic changes during pregnancy can mimic chronic liver disease. […]
Abstract: Renal dysfunction frequently develops in patients with advanced liver disease. Renal dysfunction in this setting is associated with adverse outcomes and an unfavorable prognosis. Hepatorenal […]